banner-img1.jpg
banner-img1.jpg
banner-img1.jpg
banner-img1.jpg
banner-img1.jpg

Moving forward

together

Annual Report & Accounts 2020

Download Annual Report
Financial highlights
Group operating profit $165.3m +7%
Adjusted net operating margin 14.3% +30bps
Adjusted profit before tax $152m +4%
Proposed dividend 17.00c +1%
Adjusted diluted EPS 47.71c +1%
1 Our response to COVID-19
2 Our business model
3 Our strategy
4 Market opportunity

OUR RESPONSE TO COVID-19

OUR RESPONSE TO COVID-19

The Covid-19 pandemic has affected all of our lives in some way. UDG Healthcare’s swift action and clear engagement enabled the organisation to withstand challenging circumstances, while continuing to support its key stakeholders. 

Our Senior Executive Team acted swiftly in the early stages of the outbreak, setting up a cross-functional Global Response Team and implementing a robust plan of action. The Global Response Team remains in place as the pandemic continues to fluctuate across the world.

Our response to COVID-19 (PDF)

OUR BUSINESS MODEL

OUR BUSINESS MODEL

The Group’s business model centres on the strategic development of our two growth platforms; Ashfield and Sharp.

These platforms underpin our continued organic growth and acquisition strategy.

Our disciplined approach to capital deployment allows us to pursue growth opportunities, complementary to our existing platforms.

Our Business Model

OUR STRATEGY

OUR STRATEGY

Our strategy is to grow and improve our organisation by providing market-leading outsourced services to our clients; outstanding development opportunities for our people; and long-term sustainable value for shareholders.

We achieve this strategy through three core pillars.

Our strategy

MARKET OPPORTUNITY

MARKET OPPORTUNITY

Our strategy is to grow and improve our organisation by providing market-leading outsourced services to our clients; outstanding development opportunities for our people; and long-term sustainable value for shareholders.

We achieve this strategy through three core pillars.

Market Opportunity
Chair’s Statement

A year of strength and increased resilience

Download statement (PDF)
Chief executive's review

Focus on purpose, pride in people

Download review (PDF)

Our global divisions

logo

A global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement and patient solutions.

ASHFIELD ADVISORY

Commercial strategy; strategic planning; commercial and field force benchmarking; portfolio, licensing, and development strategy; pricing, reimbursement, market access strategy; therapeutic area insight reports

ASHFIELD ENGAGE

Medical science liaisons, medical information, market access, omnichannel sales, patient engagement programmes, face-to-face, virtual and hybrid events

ASHFIELD HEALTH

Medical and scientific communications, full service marketing and creative communications, PR, corporate communications, and public affairs, internal communications, brand and launch strategy, data, digital and social media marketing

64% of Group operating profit
13.7% Net operating margin
logo

A global leader in contract packaging, clinical, manufacturing and technology services

Packaging

Commercial packaging solutions in multiple formats, including bottles, blisters, specialty and secondary packaging of injectables.

Clinical

A comprehensive and integrated clinical trial supply and management service, from pre-clinical through to commercialisation.

Manufacturing

Clinical manufacturing services including analytical services, formulation development, over-encapsulation and placebo manufacture, and sterile fill finish.

Technology

Technology services to support both commercial and clinical packaging including design, serialisation solutions and clinical IRT solutions.

36% of Group operating profit
15.5% Net operating margin